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Background: Blood cultures are essential for the diagnosis and further appropriate
treatment in children with suspected sepsis. In most hospitals, children will be empirically
treated or closely monitored for at least 48 h awaiting results of blood cultures.
Several studies have challenged the optimal duration of empiric treatment in the era of
continuously monitored blood culture systems. The aim of our study was to investigate
time-to-positivity (TTP) of blood cultures in children with proven sepsis.
Methods: The Swiss Pediatric Sepsis Study prospectively enrolled children 0–16 years
of age with blood culture positive sepsis between September 2011 and October 2015.
TTP was prospectively assessed in six participating academic pediatric hospitals by fully
automated blood culture systems.
Results: In 521 (93%) of 562 bacteremia episodes (493 children, median age 103
days, range 0 days−16.9 years) a valid TTP was available. Median TTP was 12 h
(IQR 8–17 h, range 0–109 h). By 24, 36, and 48 h, 460 (88%), 498 (96%), and 510
(98%) blood cultures, respectively, were positive. TTP was independent of age, sex,
presence of comorbidities, site of infection and severity of infection. Median TTP in all
age groups combined was shortest for group B streptococcus (8.7 h) and longest for
coagulase-negative staphylococci (16.2 h).
Conclusion: Growth of bacteria in blood cultures is detectable within 24 h in 9 of 10
children with blood culture-proven sepsis. Therefore, a strict rule to observe or treat all
children with suspected sepsis for at least 48 h is not justified.
Keywords: sepsis, children, bacteremia, blood cultures, time-to-positivity
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INTRODUCTION
Surviving Sepsis Campaign guidelines recommend obtaining
blood cultures before initiation of antibiotic treatment in
newborns, infants and children with suspected sepsis (1, 2).
Due to globally increasing antibiotic resistance rates, the World
Health Organization (WHO) has urged countries to develop
action plans against antibiotic resistance (3). Blood cultures
represent a cornerstone of antibiotic stewardship to streamline
targeted treatment and to reduce unnecessary use of antibiotics.
However, blood cultures in patients with suspected sepsis are
often negative. For example, the number of neonates with
suspected sepsis needed to treat for 1 culture proven neonatal
sepsis varies between 44 and 100 (4–6).
In most hospitals, children with suspected sepsis will be
empirically treated or closely monitored for at least 48 h awaiting
results of the blood cultures. However, this measure is based
on limited evidence. The American Academy of Pediatrics
recommends stopping antibiotic therapy in neonates treated
for suspected early-onset sepsis after 48 h if cultures remain
negative (7). Several studies in infants <90 days of age have
challenged whether this empiric treatment and observation
period is still justified in the era of continuous monitoring blood
culture systems (8–10): They demonstrated that ≥96% of all
blood cultures were positive by 36 h (9, 10) and that ceasing
antibiotic treatment after implementation of an evidence-based
care process model including an empiric treatment period of
24–36 h did not show any adverse events (8).
Limitations of currently available data on optimal use of time-
to-positivity (TTP) for decision making on empiric antibiotic
treatment in suspected sepsis are (1) lack of data on pediatric
age groups beyond early infancy, (2) lack of multicenter studies,
and (3) lack of detailed characterization of host and pathogen
features. The aim of this study was to analyse TTP in children
with blood culture positive sepsis recruited through a large
prospective multicenter population-based pediatric sepsis cohort
study and to investigate host and pathogen factors associated with
TTP.
METHODS
As part of the Swiss Pediatric Sepsis Study, we analyzed TTP
values in children with blood culture positive sepsis between
September 2011 and October 2015. Details of the Swiss Pediatric
Sepsis Study have previously been reported (11, 12). The
study was approved by the respective ethics committees of all
participating centers (Cantonal Ethics Committee, Inselspital,
University of Bern, no. KEK-029/11). Written informed consent
from patients, and/or their legal guardians was obtained before
study enrollment. In patients who fulfilled inclusion criteria but
consent was not available (224 of 521), waiver from informed
consent had been granted by the ethics commission for collection
of anonymized clinical data.
Children 0–16 years of age with bacteremia in the presence
of a systemic inflammatory response syndrome (SIRS) were
enrolled in all 10 major pediatric hospitals in Switzerland during
the study period. SIRS, severe sepsis and septic shock were
defined according to the international consensus conference on
pediatric sepsis (13). Briefly, for children beyond the neonatal
period, SIRS was defined as the presence of at least 2 of
the following four criteria, one of which had to be abnormal
temperature or leukocyte count: body temperature <36◦C or
>38.5◦C; abnormal heart rate for age; abnormal respiratory
rate for age; leukocyte count elevated or depressed for age or
>10% immature neutrophils. Age specific limits for heart rate,
respiratory rate, and leukocyte count were applied as defined
in the 2005 consensus definitions. For neonates (<28 days old,
or <44 weeks postconceptional age in premature newborns)
at least 2 of the following signs were required to be present:
tachycardia >180/min, tachypnea >60/min or increased apnea
frequency, temperature instability, leukocyte count 34 × 103
/mm3 or immature:total neutrophil ratio >0.2, capillary refill
>2 s, apathia or irritability.
Severe sepsis was defined as sepsis plus one of the following:
cardiovascular organ dysfunction or acute respiratory distress
syndrome or two or more other organ dysfunctions.
Septic shock was defined as sepsis and cardiovascular organ
dysfunction.
Each bacteremia episode received a study number and was
analyzed. The present sub-study is restricted to 6 of the 10
participating centers (designated A to F) where fully automated
blood culture systems were used, which allowed prospective
assessment of TTP. TTP was defined as the time interval
between placement of the blood culture bottle into the automated
system and detection of a positive signal. The following blood
culture systems were used: Beckton Dickinson (BD), Allschwill,
Switzerland, Bactec Aerob/Anaerob, Peds Plus/F und mycosis
IC/F Mycosis und Pedi (center A), BD Bactec FX (center B),
BD Bactec Lytic/10 Anaerobic/F, BD Bactec Aerobic Plus/F BD
Bactec Peds Plus/F (center C), bioMerieux, Geneva, Switzerland,
BacT/ALELRT PF Aerob/anaerob, BacT/ALERT FA Aerob,
BacTALERT FN Anaerob (center D), BD Bactec peds plus/F,
BD Bactec lytic/10 anaerobic/f, BD Bactec plus aerobic/F (center
E), BD Bactec plus aerobic/F, BD Bactec plus anaerobic/F, BD
Bactec peds plus (center F). Centers B to F used fully automated
blood culture systems from the beginning of the study, center A
introduced it mid-2013.
Early-onset neonatal sepsis was defined as sepsis occurring
<72 h of age and late-onset neonatal sepsis as ≥72 h in
term infants and 72 h of age to <44 weeks of gestational
age in premature infants. Hospital-acquired infection (i.e.,
blood culture obtained >48 h after admission) and central
line-associated bloodstream infection (CLABSI) were defined
according to the criteria of the Centers for Disease Control and
Prevention (CDC) (14). In patients with suspected sepsis, positive
blood cultures were only included if contamination was ruled out
by the treating physician. The definition of contamination was
based on the following criteria: absence of a central line at the
time the blood culture was taken; blood culture growing a mixed
flora of different coagulase-negative staphylococci (CoNS); and
blood cultures growing pathogens considered as contaminants by
the treating physician.
Chronic inborn or acquired medical conditions, recent
surgery, or burns where considered as comorbidities and
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were categorized according to the pediatric complex chronic
conditions classification system, version 2 (15).
Pre-planned Subgroup Analyses and
Statistics
For statistical data analysis all extracted data was stored in
spreadsheets (Microsoft Excel 2010, version 14.0). For descriptive
analyses, the total number of cases and all cases stratified
by study center were analyzed. For comparative analyses of
TTP, we analyzed cases from all study centers combined and
all bacteria combined, stratified by sex. For further analyses,
cases were stratified by study centers, the 5 most frequently
isolated organisms, age (0–27 days, 28–365 days, 1–5 years, 6–
10 years and >10 years), focus of infection, outcome/severity
of infection, prematurity, comorbidity, and community-acquired
vs. nosocomial infection.
Descriptive statistics are presented as median (IQR) for
continuous variables and as frequencies (%) for categorical
variables. We fitted a generalized linear model with a log-link
function and Gamma distribution for potential determinants of
TTP with age, gender, presence of comorbidity, sepsis severity,
site of infection, and pathogens using a random effect to
correct for correlation between multiple observations at the
same hospital. We added 0.01 h to all TTP measurements to
remove zero values. We separately fitted univariable models or
all variables and a multivariable model containing all variables.
We present the results of the multivariable model as estimates
(multiplicative factor by which to multiply the TTP of the
respective reference group) with 95% CIs and p-values of
likelihood ratio testing. We additionally fitted a multilevel
binomial regression model for potential determinants of death
within the first 30 days after sepsis onset with the TTP (adjusting
for patient age, sex, presence of comorbidity, severity of sepsis,
site of infection, and pathogen) using a random effect to
correct for correlation between multiple observations at the same
hospital.
Statistical significance was defined at a two-sided p-value of
<0.05. We did regression analyses with R version 3.4.3.
RESULTS
General Characteristics
During the study period, 493 patients with 562 bacteremia
episodes were enrolled in study centers A-F. Of these, 521
(93%) had blood culture TTP recorded and they are the subject
of these analyses; 311 (60%) of 521 episodes occurred in
male patients with no difference between infants <90 days of
age and patients >90 days of age (Supplement Table 1). Median
age of patients was 103 days (range: 0 days−16.9 years; IQR 11
days−3.8 years); 196 (38%) were neonates (i.e., ≤28 days old),
257 (49%) were <90 days old and 125 (24%) were <365 days old.
In 291 (56%) episodes the sepsis was community-acquired and
86 (30%) of these patients had at least 1 comorbidity. In 230
(44%) episodes the sepsis was hospital-acquired and 205 (89%)
of these patients had at least 1 comorbidity.
In 417 (80%) episodes a focus for sepsis could be identified
and most commonly this was related to a central venous catheter
Case fatality rate was 7% (N = 37). Children <90 days of age had
significantly more episodes with severe sepsis than children >90
days of age (Supplement Table 1).
Blood culture isolates by study center are summarized in
Table 1. Overall 336 (64%) were Gram-positive and 185 (36%)
were Gram-negative pathogens. The distribution of pathogens
stratified by age, i.e., <90 days and >90 days, is shown in
Supplement Table 1.
Time to Positivity and Associations With
Pathogens and Host Characteristics
Median TTP was 11.7 h (IQR 8.3–17.1) with minimal variability
between different study centers (Supplement Table 2).
Table 2 shows results of multivariable analysis of TTP by
patient and disease characteristics. TTP was independent of age,
sex, presence of a comorbidity (see Table 3), site of infection, and
severity of sepsis. Compared to coagulase-negative staphylococci,
TABLE 1 | Bacterial pathogens isolated from blood cultures by study center (A-F).
A
n (%)
B
n (%)
C
n (%)
D
n (%)
E
n (%)
F
n (%)
Total
n (%)
Escherichia coli 21 (20) 6 (11) 18 (13) 21 (24) 23 (24) 8 (22) 97 (19)
Coagulase-
negative-
staphylococci
7 (7) 15 (28) 40 (29) 6 (7) 13 (13) 2 (5) 83 (16)
Staphylococcus
aureus
13 (12) 9 (17) 18 (1) 11 (12) 13 (13) 8 (22) 77 (14)
Group B
streptococcus
11 (10) 12 (22) 4 (3) 4 (4) 10 (10) 3 (8) 47 (9)
Streptococcus
pneumoniae
13 (12) 1 (2) 9 (6) 8 (9) 8 (8) 8 (22) 47 (9)
Group A
streptococcus
5 (5) 0 (0) 4 (3) 8 (9) 5 (5) 2 (5) 24 (5)
Enterococcus spp. 8 (8) 1 (2) 4 (3) 2 (2) 2 (2) 2 (5) 19 (4)
Klebsiella spp. 7 (7) 1 (2) 11 (8) 1 (1) 4 (4) 1 (3) 25 (5)
Neisseria
meningitidis
2 (2) 0 (0) 4 (3) 3 (3) 4 (4) 2 (5) 13 (2)
Pseudomonas
aeruginosa
4 (4) 0 (0) 3 (2) 1 (1) 2 (2) 0 (0) 11 (2)
Haemophilus
influenzae
1 (1) 0 (0) 2 (1) 1 (1) 3 (3) 0 (0) 6 (1)
Other
Gram-negative
pathogens
11 (10) 2 (4) 10 (7) 2 (2) 4 (4) 0 (0) 29 (6)
Other
Gram-positive
pathogens•
2 (2) 7 (13) 15 (11) 6 (7) 6 (6) 1 (3) 38 (7)
Total 105 54 139 89 97 37 521
 Stenotrophomonas maltophilia, Serratia marcescens, Serratia liquefaciens, Citrobacter
Sedlakii, Citrobacter freundii, Elizabethkingia meningoseptica, Salmonella group B,
Salmonella group C, Acinetobacter Iwofii, Enterobacter cloacae, Capnocytophaga sp.,
Proteus mirabilis, Cardiobacterium hominis
•Bifidobacterium spp., Fusobacterium nucleatum, Fusobacterium
necrophorum, Streptococcus bovis, Lactobacillus spp., Streptococcus mitis,
Streptococcus equi, Streptococcus, salivarius, Streptococcus anginosus, Streptococcus
sanguinis, Streptococcus viridans, Listeria monocytogenes, Micrococcus luteus, Bacillus
cereus, Bacillus pumilus, Rothia mucilaginosa,
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TABLE 2 | Median (IQR) TTP by patient and infection characteristics and adjusted* estimates of TTP investigating potential predictive factors in a generalized linear model.
n (%) TTP, Median (IQR), h Multivariable model
Estimated TTP (95% CI)a Adjusted p-valueb
Age groups p = 1.0
<28 days 196 (38%) 11.3 (7.57–18.7) Reference
28–365 days 125 (24%) 11.0 (8.40–15.6) 0.95 (0.79–1.13)
1–4 years 93 (18%) 12.0 (9.12–16.2) 1.01 (0.82–1.25)
5–9 years 53 (10%) 11.9 (9.00–16.2) 0.97 (0.75–1.25)
10–16 years 54 (10%) 12.0 (8.62–16.5) 0.94 (0.73–1.20)
Sex p = 0.3
Male sex 311 (60%) 11.3 (8.12–17.2) Reference
Female sex 210 (40%) 12.0 (8.50–16.8) 1.07 (0.94–1.22)
Comorbidity p = 0.1
No comorbidity 230 (44%) 12.0 (8.93–16.9) Reference
Comorbidity present 291 (56%) 11.0 (7.50–17.1) 0.85 (0.72–1.01)
Severity of sepsis p = 0.9
Sepsis 324 (62%) 11.7 (8.67–16.6) Reference
Severe sepsis 100 (19%) 12.4 (7.56–19.6) 0.96 (0.80–1.15)
Septic shock 97 (19%) 11.3 (7.50–15.1) 1.00 (0.84–1.19)
Site or type of infection p = 0.1
Central-line associated
bloostream
151 (29%) 11.9 (7.65–18.1) Reference
Primary bloodstream 104 (20%) 10.1 (7.17–14.4) 0.94 (0.76–1.17)
Urinary tract 56 (11%) 11.0 (8.12–15.4) 1.27 (0.97–1.65)
Pneumonia 45 (9%) 13.2 (10.3–16.2) 1.28 (0.95–1.74)
Central nervous system 40 (8%) 10.0 (8.33–14.7) 0.94 (0.69–1.28)
Gastrointestinal system 32 (6%) 11.8 (7.88–18.2) 1.32 (0.99–1.76)
Bones and joints 30 (6%) 14.1 (11.3–20.1) 1.04 (0.72–1.49)
Skin and soft tissue 30 (6%) 12.5 (9.35–16.7) 1.06 (0.79–1.42)
Other specific infection
typeb
33 (6%) 12.0 (9.00–19.5) 1.20 (0.88–1.62)
Pathogens p < 0.001
Coagulase-negative
staphylococci
84 (16%) 16.2 (10.4–23.1) Reference
Staphylococcus aureus 77 (15%) 14.0 (9.12–17.1) 0.74 (0.57–0.95)
Group B streptococci 47 (9%) 8.70 (5.95–10.2) 0.44 (0.33–0.59)
Streptococcus
pneumoniae
46 (9%) 11.4 (9.05–13.9) 0.53 (0.37–0.74)
Other Gram-positive
bacteriac
82 (16%) 13.2 (10.0–19.8) 0.81 (0.63–1.03)
Escherichia coli 97 (19%) 9.20 (6.68–12.0) 0.56 (0.43–0.71)
Other Gram-negative
bacteriad
88 (17%) 11.9 (8.54–18.7) 0.80 (0.62–1.04)
*The adjusted model was adjusted for all variables listed
aValues and 95% CI are relative to the defined reference group
bP-value from likelihood ratio test. Endocarditis, toxic shock syndrome, ear, nose, and throat infection, and other non-specified focal infections.
cEnterococcus spp., group A streptococcus, viridans group streptococci, other Gram positive bacteria.
dHaemophilus influenzae, Klebsiella spp., Neisseria meningitidis, Pseudomonas aeruginosa, other Gram negative bacteria.
TTP was shorter in Staphylococcus aureus (−26%, 95% CI 5–
43), group B streptococci (−56%, 95% CI 41–67), Streptococcus
pneumoniae (−47%, 95% CI 26–63), and Escherichia coli (−44%,
95% CI 29–57). TTP of all organisms is demonstrated in
Figures 1A,B and TTP of selected bacterial pathogens separated
by different age groups in Figure 2.
Of the 521 sepsis episodes, 100 (19%) were severe and 97
(19%) presented with septic shock. There was no significant
association between 30-day in hospital mortality and TTP: in
children who died in the first 30 days after sepsis onset, median
TTP was 12.0 (IQR 7.50–16.3) compared to 11.7 (IQR 8.4–17.1)
in those who survived (p= 0.8).
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TABLE 3 | Comorbidities detected in patients with 521 episodes of blood
culture-proven sepsis.
Number (%) of
episodesc
Neurological or neuromuscular 17 (3)
Cardiovascular 35 (7)
Respiratory 30 (6)
Renal and urological 12 (2)
Gastrointestinal 37 (7)
Hematological or immunological 8 (2)
Metabolic 11 (2)
Other congenital or genetic defect 20 (4)
Malignant disease 46 (9)
Neonatala 122 (23)
Surgery or burn 40 (8)
Technology dependenceb 19 (4)
Solid organ transplantation 2 (<1)
aGestational age <27 weeks, or birthweight <750g, or history of mechanical ventilation,
or history of necrotising colitis. bCentral line or urinary catheter or ventriculoperitoneal
shunt system present at sepsis onset, or total parental nutrition in a child that does not
have any other comorbidity.
cMore than one comorbidity might be present in a sepsis episode; therefore, numbers
and percentages do not add up to 521 and 100, respectively.
Characteristics of Sepsis Episodes
According to TTP Thresholds (TTP >24 to
≤36h, >36 to ≤48h and >48h)
By 24 h, 460 (88%) of 521 blood cultures were positive as were
498 (96%) and 510 (98%) by 36 and 48 h, respectively (Table 4).
When comparing infants <90 days of age with those >90 days
of age, proportions of positive blood cultures within 24, 36,
and 48 h were almost identical with 88% vs. 89%, 96% vs. 95%,
and 98% vs. 97%, respectively. Of the 11 blood cultures which
became positive after 48 h, 4 were obtained in infants <90 days
of age including 3 preterm babies with a gestational age of 25+6
weeks, 26+2 weeks and 28+4 weeks, representing 1.6% of all
positive blood cultures in this age group. Three each grew E. coli,
Bifidobacterium longum and Fusobacterium species, one grew
Staphylococcus aureus and one grew Capnocytophaga species.
Two of the 3 children with E. coli septicemia and a TTP of
>48 h had urinary tract infections and no organ dysfunction. The
third child, without any comorbidities, suffered from peritonitis
with septic shock. Of the other 8 episodes with TTP >48 h, 4
patients presented with signs of septic shock. One of them, an
extremely premature baby (gestational age 25+6), died. Similar
to the overall proportion of patients with comorbidities (69%), 6
(55%) of the 11 patients with TTP >48 h had a comorbidity and
2 of them developed severe sepsis with septic shock.
DISCUSSION
We report on prospectively assessed TTP in a large national
prospective cohort of children with blood culture proven sepsis.
In our multivariate analysis, TTP was only dependent on
FIGURE 1 | (A) TTP of all organisms, Kaplan-Meier-Curve. (B) cutout of (A).
pathogens, whereas sex, age, site of infection, presence of a
comorbidity and severity of sepsis were not relevant.
Nine of 10 blood cultures turned positive within 24 h and 19
of 20 turned positive within 36 h after incubation. These findings
contrast with the wide practice to treat children with suspected
sepsis with antibiotics for >48 h while waiting for blood culture
results. This “48 h rule” has historically evolved in the era prior to
automated TTP recording systems. Our results indicate the need
to critically reevaluate this rule.
Blood cultures represent one of the most widely used test
in pediatrics, despite a low positivity rate, issues related to
false positive tests due to contaminations, and false negative
tests due to antibiotic pre-treatment and small inocula (16–
18)., These limitations are increased if the cultures are obtained
incorrectly, especially if the volume is inadequate (19). However,
if positive, they confirm the diagnosis of bacteremia or sepsis
and appropriate antibiotic treatment can be initiated (20). Fully
automated blood culture systems with recording of TTP have
evolved and several studies have since then been conducted to
challenge the minimum of 48 h to observe or even treat a child
with suspected bacteremia used by many centers (9, 10).
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FIGURE 2 | Blood culture TTP in selected bacterial pathogens by age group. aGroup A streptococcus, viridans group streptococci, other gram positive bacteria.
bKlebsiella species, Neisseria meningitides, Pseudomonas aeruginosa, other gram negative bacteria.
TABLE 4 | Patient characteristics with sepsis episodes by TTP thresholds.
TTP threshold n (%)
≤ 24 h >24 - ≤36 h >36 - ≤48 h >48 h
Overall n 460 38 12 11
Age (d) <90 226 (49%) 20 (53%) 7 (58%) 4 (36%)
Prematurity ≤28+0 66 (14%) 9 (16%) 4 (33%) 2 (18%)
28+1 −31+6 32 (7%) 5 (13%) 1 (8%) 1 (9%)
>32+0 – 36+6 35 (8%) 1 (3%) 1 (8%) –
HAI 199 (43%) 18 (47%) 8 (67%) 5 (45%)
Severity Severe sepsis 82 (18%) 13 (34%) 5 (42%) –
Septic shock 87 (19%) 5 (13%) 1 (8%) 4 (36%)
Fatal
outcome
32 (7%) 2 (5%) 2 (17%) 1 (9%)
Comorbidity 257 (56%) 19 (50%) 9 (75%) 6 (55%)
Focus
present
295 (64%) 27 (71%) 12 (100%) 10 (91%)
The recording of TTP in a large prospective population-based
cohort of children with confirmed sepsis can inform clinicians
in decision making about the appropriate length of empiric
antibiotic treatment in the absence of a positive blood culture.
Most clinicians stop antibiotic treatment if (a) the blood culture
remains negative, (b) there is no focus of infection that would
require continued antibiotic treatment, and (c) the clinical course
of the disease is favorable. Yet, the chosen threshold of time
after which blood cultures are highly unlikely to become positive
will have a large influence on duration of antibiotic treatment.
Longer periods of antibiotic treatment expose patients to risks
such as medication errors, adverse events including selection of
antibiotic resistance, nosocomial infections. Further, antibiotics
increase the risk of necrotizing enterocolitis and death in preterm
newborns (21). Moreover, prolonged hospital stays do increase
health care costs and stress to patients, their relatives, and care-
givers (22–24).
Our findings support previous studies performed in infants
<90 days of age investigating TTP, which suggested that a
shorter observation period and/or empiric antibiotic treatment,
i.e., 24 or 36 h rather than the current practice of 48 h, might
be appropriate (8–10). The decision by the treating physician to
stop or continue antibiotics is not only based on blood culture
result but also patient risk factors, clinical signs and severity
of disease on presentation and during the course, response to
treatment, inflammatory markers, and age. Procalcitonin-guided
decision making has been shown to also guide the duration of
antibiotic treatment in neonates with suspected early-onset sepsis
(25, 26). It is well established that the likelihood to isolate an
organism from blood culture increases with the amount of blood
obtained for inoculation. Therefore, particularly in neonates
blood cultures are often false negative (27). Unfortunately, there
is limited data on the optimal volume in the pediatric age groups
and different recommendations exist (28, 29).
In our study, the sensitivity of blood cultures increased only
marginally (i.e., by 2%) when comparing a 48 h incubation
threshold with a 36 h period. This demonstrates that the
48 h cut-off is arbitrary and based on tradition rather than
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strong evidence. However, the difficulty of decision making is
exemplified by the fact that the longest TTP values in our study
were 68 and 109 h for E. coli in the age groups 28–365 days and 1–
5 years, respectively (Figure 2). Furthermore, our study was not
designed to evaluate the prediction of which children, presenting
with SIRS, will have a positive blood culture beyond 24 or 36 h.
Hence, individual factors always need to be taken into account for
decision making. Also, if the patient’s clinical course is favorable
and antibiotic treatment is stopped in the presence of a negative
blood culture, parents still need to be advised to recognize signs
and symptoms of concern and they need to be contactable for
arrangement of a clinical reassessment as true pathogens might
be detected after 36 or 48 h.
Not surprisingly, and also described in the literature, TTP
varies by pathogen (30, 31). In our study, median TTP values
were shortest for E. coli and GBS (approximately 9 h each) and
longest for S. aureus and CoNS (14 and 16 h, respectively).
While some studies found short TTP for organisms such as
Enterobacter, E. coli or S. aureus correlated with poor outcomes
in adults (30–32), median TTP value—irrespective of pathogen—
did not predict poor outcome or admission and treatment on
PICU in our study.
Also, a comparison of children <90 days of age and >90 days
of age, as most studies in the literature investigated only children
<90 days of age (9, 10), did not show any significant difference
in their median TTP (11 h vs. 12 h). However, as infants <90
days of age and particularly neonates, represent a special pediatric
cohort, especially in regards to their management, our data
provides valuable information also on children >90 days of
age. Children <90 days of age had significantly different sites
of infection (e.g., primary blood stream infection) and sepsis
episodes tend to be more severe. Also, as expected, pathogens
differed significantly between these 2 groups, with Escherichia coli
and CONS being the most common pathogens in infants <90
days of age and that is, in regards to Escherichia coli consistent
with the literature (9, 10).
We did not see any significant differences in median TTP for
children with or without comorbidity. A study in adults looking
especially at patients with solid tumors or hematological disease
found significantly lower TTPs in these patients compared with
patients with benign tumors (33).
In our study, 42% of sepsis cases were hospital-acquired
infections. Similar magnitudes have been reported before (34,
35). In a retrospective cohort study in South Africa investigating
blood culture positive bacterial and fungal infections in children
with a median age of 11.5 months, the proportion of hospital-
acquired infections was 53.5% (34). Similarly, a study in South
African neonates revealed a proportion of nosocomial infections
of 62.2% of all positive blood cultures (35).
Whereas, as already mentioned above, most previous studies
(retrospective or observational) investigatedmainly neonates and
infants <90 days of age or specific foci of infection (9, 10,
36), strengths of this study include the prospective, multicenter,
population-based design and recruitment, use of a strict case
definition, and inclusion of the entire pediatric age range with
detailed capture of host and pathogen characteristics.
Our study had several limitations: Study centers that did
not use automated laboratory systems had to be excluded.
TTP “sensu strictu” (i.e., duration of incubation until blood
culture becomes positive) must be distinguished from TTP
“sensu latu” (i.e., time interval between collection of blood for
culture and report of positive result to the treating physician).
In our and most previously reported studies, TTP sensu
strictu was analyzed. For patient management in the clinical
context, TTP sensu latu reflects reality better than TTP sensu
strictu and should be the subject of future studies. Also, the
study protocol did not specify the maximum time allowed
between obtaining blood cultures and processing them in the
microbiology laboratory. Thus, bacteria may have started to
replicate earlier in some episodes than formally measured,
thereby leading to shorter TTP values. Furthermore, different
blood culture systems were used in different study centers
and the amount of inoculated blood, which is defined in each
center according to the recommendations either given by the
culture systems manufacturers or by local hospital guidelines,
was not recorded. While these factors probably have increased
heterogeneity of TTP findings in our study, they reflect a real
world scenario in a pragmatic study design (37–39). Also, our
study included children with comorbidities and it would have
been interesting to carry out subgroup analyses on populations
of special interest such as neutropenic patients. However, as
numbers of specific comorbidities were low, such analyses would
not have been meaningful. Finally, our study was based on
children with positive blood cultures, and we cannot comment
on blood culture negative bacterial infections. In addition, the
study was not designed to analyse the performance of other
clinical and laboratory criteria to guide antimicrobial therapy.
As per international best practice, infectious diseases and/or
antimicrobial stewardship team advice was routinely sought in
the study centers once blood culture positivity was known.
In conclusion, blood cultures were positive within 36 h of
incubation in 90% of children with sepsis. TTP was <24 h in
the great majority of children with sepsis, but occasionally it was
>36–48 h in individual sepsis episodes. Therefore, a strict and
general rule to treat or observe all children for at least 48 h is not
justified; rather, the decision to continue with empiric antibiotic
treatment in the absence of a positive blood culture should be
reconsidered after 24 and 36 h and antibiotic treatment should
be stopped if the diagnosis of sepsis cannot be held up. Future
studies are needed to test whether empiric antibiotic treatment
in children with negative blood cultures can be safely reduced to
<48 h and to identify factors that would allow to predict which
children with SIRS will still have positive blood cultures beyond
36 h of incubation. Still, TTP is an important pillar on which
the decisions for or against antibiotic treatment and its duration
should be based. Therefore, standardized measurement of TTP
in children with sepsis continues to be valuable, and ongoing
analyses should be encouraged.
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